Cargando…
Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial)
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668491/ https://www.ncbi.nlm.nih.gov/pubmed/28751769 http://dx.doi.org/10.1038/leu.2017.242 |
| _version_ | 1783275683018964992 |
|---|---|
| author | Bug, G Burchert, A Wagner, E-M Kröger, N Berg, T Güller, S Metzelder, S K Wolf, A Hünecke, S Bader, P Schetelig, J Serve, H Ottmann, O G |
| author_facet | Bug, G Burchert, A Wagner, E-M Kröger, N Berg, T Güller, S Metzelder, S K Wolf, A Hünecke, S Bader, P Schetelig, J Serve, H Ottmann, O G |
| author_sort | Bug, G |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5668491 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-56684912017-11-07 Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial) Bug, G Burchert, A Wagner, E-M Kröger, N Berg, T Güller, S Metzelder, S K Wolf, A Hünecke, S Bader, P Schetelig, J Serve, H Ottmann, O G Leukemia Letter to the Editor Nature Publishing Group 2017-11 2017-09-01 /pmc/articles/PMC5668491/ /pubmed/28751769 http://dx.doi.org/10.1038/leu.2017.242 Text en Copyright © 2017 The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
| spellingShingle | Letter to the Editor Bug, G Burchert, A Wagner, E-M Kröger, N Berg, T Güller, S Metzelder, S K Wolf, A Hünecke, S Bader, P Schetelig, J Serve, H Ottmann, O G Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial) |
| title | Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial) |
| title_full | Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial) |
| title_fullStr | Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial) |
| title_full_unstemmed | Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial) |
| title_short | Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial) |
| title_sort | phase i/ii study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk mds or aml (panobest trial) |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668491/ https://www.ncbi.nlm.nih.gov/pubmed/28751769 http://dx.doi.org/10.1038/leu.2017.242 |
| work_keys_str_mv | AT bugg phaseiiistudyofthedeacetylaseinhibitorpanobinostatafterallogeneicstemcelltransplantationinpatientswithhighriskmdsoramlpanobesttrial AT burcherta phaseiiistudyofthedeacetylaseinhibitorpanobinostatafterallogeneicstemcelltransplantationinpatientswithhighriskmdsoramlpanobesttrial AT wagnerem phaseiiistudyofthedeacetylaseinhibitorpanobinostatafterallogeneicstemcelltransplantationinpatientswithhighriskmdsoramlpanobesttrial AT krogern phaseiiistudyofthedeacetylaseinhibitorpanobinostatafterallogeneicstemcelltransplantationinpatientswithhighriskmdsoramlpanobesttrial AT bergt phaseiiistudyofthedeacetylaseinhibitorpanobinostatafterallogeneicstemcelltransplantationinpatientswithhighriskmdsoramlpanobesttrial AT gullers phaseiiistudyofthedeacetylaseinhibitorpanobinostatafterallogeneicstemcelltransplantationinpatientswithhighriskmdsoramlpanobesttrial AT metzeldersk phaseiiistudyofthedeacetylaseinhibitorpanobinostatafterallogeneicstemcelltransplantationinpatientswithhighriskmdsoramlpanobesttrial AT wolfa phaseiiistudyofthedeacetylaseinhibitorpanobinostatafterallogeneicstemcelltransplantationinpatientswithhighriskmdsoramlpanobesttrial AT huneckes phaseiiistudyofthedeacetylaseinhibitorpanobinostatafterallogeneicstemcelltransplantationinpatientswithhighriskmdsoramlpanobesttrial AT baderp phaseiiistudyofthedeacetylaseinhibitorpanobinostatafterallogeneicstemcelltransplantationinpatientswithhighriskmdsoramlpanobesttrial AT scheteligj phaseiiistudyofthedeacetylaseinhibitorpanobinostatafterallogeneicstemcelltransplantationinpatientswithhighriskmdsoramlpanobesttrial AT serveh phaseiiistudyofthedeacetylaseinhibitorpanobinostatafterallogeneicstemcelltransplantationinpatientswithhighriskmdsoramlpanobesttrial AT ottmannog phaseiiistudyofthedeacetylaseinhibitorpanobinostatafterallogeneicstemcelltransplantationinpatientswithhighriskmdsoramlpanobesttrial |